Skip to main content

Table 2 Fatty liver index (FLI), its individual components and various biomarkers of liver function, inflammation and lipid status according to lifestyle risk factor scores. The percentages show the proportions of individuals exceeding the cut-offs for each parameter

From: Combined effects of lifestyle risk factors on fatty liver index

Men
Risk score01234567–8
FLI18.0 ± 12.32.4%25.4 ± 17.05.5%37.2 ± 22.718.0%49.4 ± 25.437.6%55.7 ± 27.746.7%62.6 ± 27.859.0%67.0 ± 26.263.3%79.9 ± 21.281.9%
BMI, kg/m223.1 ± 1.30.0%23.9 ± 2.021.4%25.3 ± 2.754.1%26.6 ± 3.173.5%27.5 ± 4.076.4%28.2 ± 4.378.4%28.6 ± 4.983.0%30.8 ± 3.7100.0%
Waist, cm82.5 ± 5.74.2%86.0 ± 6.713.0%89.8 ± 8.433.5%94.1 ± 9.152.7%96.3 ± 11.357.0%98.7 ± 11.963.7%100.2 ± 12.972.4%105.8 ± 11.185.1%
GGT, U/L20.7 (19–22)1.8%23.3 (22–24)5.1%25.6 (25–26)5.4%31.0 (30–32)12.1%35.3 (34–37)18.7%40.6 (39–43)24.2%48.6 (45–53)36.7%56.7 (49–65)41.5%
Trigl, mmol/L1.02 (1.0–1.1)12.5%1.06 (1.0–1.1)14.3%1.24 (1.2–1.3)24.4%1.36 (1.3–1.4)31.2%1.46 (1.4–1.5)35.8%1.60 (1.5–1.7)41.8%1.68 (1.6–1.8)47.8%2.05 (1.8–2.3)59.6%
ALT, U/L22.1 (20–25)0.0%23.4 (22–24)2.9%25.8 (25–27)6.7%28.6 (28–30)11.5%30.6 (29–32)16.3%31.4 (29–33)15.9%34.1 (31–38)25.0%43.7 (38–51)32.0%
CRP, mg/L0.53 (0.5–0.6)4.9%0.62 (0.6–0.7)7.2%0.81 (0.8–0.9)11.6%0.93 (0.9–1.0)12.1%1.19 (1.1–1.3)16.9%1.38 (1.3–1.5)21.9%1.74 (1.5–2.0)31.0%2.09 (1.7–2.6)35.5%
Chol, mmol/L4.94 (4.8–5.1)45.8%5.09 (5.0–5.2)55.8%5.28 (5.2–5.3)64.5%5.50 (5.4–5.6)72.3%5.49 (5.4–5.6)70.7%5.60 (5.5–5.7)73.3%5.73 (5.6–5.9)74.8%5.96 (5.7–6.2)84.0%
HDL, mmol/L1.33 (1.3–1.4)9.5%1.36 (1.3–1.4)8.7%1.29 (1.3–1.3)15.7%1.27 (1.3–1.3)15.6%1.26 (1.2–1.3)17.5%1.26 (1.2–1.3)18.6%1.25 (1.2–1.3)20.5%1.23 (1.2–1.3)16.0%
LDL, mmol/L3.03 (2.9–3.2)49.5%3.04 (3.0–3.1)57.0%3.27 (3.2–3.3)65.8%3.39 (3.3–3.4)71.4%3.39 (3.3–3.5)70.3%3.36 (3.3–3.5)68.7%3.60 (3.5–3.7)77.9%3.52 (3.3–3.8)70.3%
Women
Risk score01234567–8
FLI8.4 ± 6.80.0%11.1 ± 10.70.2%17.0 ± 16.53.5%27.9 ± 24.313.2%40.6 ± 28.427.7%45.3 ± 30.734.3%54.5 ± 29.343.9%71.1 ± 23.173.5%
BMI, kg/m222.3 ± 1.60.0%22.8 ± 2.411.7%24.1 ± 3.234.8%26.2 ± 4.460.0%28.3 ± 5.175.9%29.1 ± 5.776.0%30.3 ± 5.587.8%32.8 ± 3.5100.0%
Waist, cm73.6 ± 5.915.4%75.0 ± 7.124.3%78.2 ± 8.739.1%83.0 ± 11.258.7%88.5 ± 13.073.8%90.1 ± 13.774.9%93.3 ± 13.184.9%99.9 ± 11.197.1%
GGT, U/L15.8 (15–17)5.9%16.3 (16–17)4.3%17.5 (17–18)4.7%19.1 (19–20)8.9%21.9 (21–23)10.6%25.2 (24–27)17.6%28.4 (25–32)25.9%33.3 (27–41)26.5%
Trigl, mmol/L0.87 (0.8–0.9)5.6%0.90 (0.9–0.9)6.4%0.95 (0.9–1.0)8.0%1.04 (1.0–1.1)13.3%1.12 (1.1–1.2)17.0%1.15 (1.1–1.2)19.5%1.24 (1.1–1.3)25.9%1.50 (1.3–1.8)32.4%
ALT, U/L17.0 (16–18)3.3%17.4 (17–18)6.6%17.5 (17–18)4.4%18.1 (18–19)6.7%19.3 (19–20)9.2%20.2 (19–22)8.3%22.1 (19–25)15.3%24.1 (17–34)9.1%
CRP, mg/L0.64 (0.6–0.7)9.1%0.76 (0.7–0.8)10.8%0.83 (0.8–0.9)12.4%1.07 (1.0–1.1)17.7%1.42 (1.3–1.5)27.0%1.43 (1.3–1.6)26.6%2.05 (1.7–2.5)37.2%2.99 (2.2–4.1)52.9%
Chol, mmol/L5.01 (4.9–5.1)52.7%5.09 (5.0–5.1)53.3%5.21 (5.2–5.3)59.4%5.32 (5.3–5.4)62.6%5.30 (5.2–5.4)63.8%5.29 (5.2–5.4)61.4%5.39 (5.2–5.5)66.2%5.67 (5.3–6.1)76.5%
HDL, mmol/L1.66 (1.6–1.7)5.9%1.62 (1.6–1.6)7.7%1.60 (1.6–1.6)10.4%1.55 (1.5–1.6)13.6%1.50 (1.5–1.5)19.8%1.50 (1.5–1.5)21.9%1.50 (1.4–1.6)20.3%1.34 (1.2–1.4)26.5%
LDL, mmol/L2.76 (2.7–2.9)43.0%2.87 (2.8–2.9)43.7%2.96 (2.9–3.0)50.8%3.07 (3.0–3.1)57.0%3.11 (3.0–3.2)57.7%3.08 (3.0–3.2)55.6%3.15 (3.0–3.3)60.4%3.29 (2.9–3.7)72.7%
  1. The values are expressed as mean ± SD (FLI, BMI, waist circumference) or as geometric means and 95% confidence intervals (GGT, triglycerides, ALT, CRP, cholesterol, HDL, LDL)
  2. p < 0.0005 for linear trend for both mean values and proportions, except p = 0.001 for ALT data on proportions among women